Race Oncology Eyes Market Expansion With New Shares

TipRanksAug 9 02:27 ET

Race Oncology Announces New Stock Listing

TipRanksAug 5 23:47 ET

Race Oncology Concludes Phase Two Trial of Bisantrene for Leukaemia Treatment; Shares Down 3%

MT NewswiresJul 29 21:44 ET

2 ASX Healthcare Shares Outperforming on Big News

The Motley FoolJul 29 21:20 ET

Race Oncology RC110 Bisantrene Treatment Meets Efficacy Goals in Phase 2 Acute Myeloid Leukaemia Trial

Investing.com Jul 29 20:55 ET

Race Oncology Enjoys Strong Quarter on the Clinical, Regulatory and Corporate Fronts

Investing.com Jul 28 21:51 ET